SELLAS Life Sciences Group Return on Net Operating Assets Insights

SELLAS Life Sciences Group, Inc. (SLS)

4.46 -0.18 (-3.88%) USD | NASDAQ | Apr 24, 16:00

4.61 +0.15 (+3.36%) After-Hours: 20:00

View Return on Net Operating Assets for SLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Spero Therapeutics, Inc.	Upgrade
Recursion Pharmaceuticals, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade